Bismuth(III) benzohydroxamates: powerful antibacterial activity against Helicobacter pylori and hydrolysis to a unique Bi 34 oxido-cluster [Bi 34 O 22 (BHA) 22 (H-BHA) 14 (DMSO) 6 (BHA) 3 ] N in DMSO/toluene results in hydrolysis to the first structurally authenticated {Bi 34 } oxido-cluster [Bi 34 O 22 (BHA) 22 (H-BHA) 14 (DMSO) 6 ] 4.
In conjunction with other antibiotics bismuth subsalicylate (BSS) and colloidal bismuth subcitrate (CBS) are taken therapeutically in the treatment and eradication of the ulcer and cancer causing bacterium Helicobacter pylori.
1,2 Recent studies have begun to uncover mechanisms by which bismuth is toxic to the bacterium, including disrupting the enzymes urease and alcohol dehydrogenase, and interfering with Fe 3+ regulating proteins. 3 While having a strong affinity for S-based ligands, such as glutathione and metallothionein, 4 Bi 3+ is also known to compete with ferric ions in vivo with predominantly N-and O-binding biomolecules. 5 In human serum this involves strong complexation with transferrin and lactoferrin, and it has been speculated that this is an important factor in the unusually low toxicity of bismuth in humans. 6 In H. pylori, Fe 3+ limitation mimics the antimicrobial effects of bismuth, though the mode of action appears unrelated, while increasing Fe 3+ concentration acts to protect the bacterium against low concentrations of Bi 3+ by outcompeting the heavy metal for transport proteins. 7 To survive many bacteria rely on the ability to sequester and transport ferric ions by use of strong metal chelators, known as siderophores. 8 3 prevents a rapid reduction of Bi(III) to Bi(0) as indicated by the appearance of a grey solid. Complex 1, comprises only hydroxamate di-anions.
The solid was found to be only soluble in the highly polar solvents DMSO and DMF.
In an attempt to obtain crystals of the complex the solid was dissolved in DMSO/toluene. However, rather than crystals of 1 the pale yellow crystals which formed are of a unique bismuth oxido-cluster; [Bi 34 O 22 (BHA) 22 (H-BHA) 14 DMSO 6 ] 4. Formed slowly through hydrolysis this oxido-cluster contains both the
Interestingly, the 3 : 1 stoichiometric reaction of H 2 -BHA with Bi(O t Bu) 3 in dry THF resulted only in the isolation of the mixed anion species; [Bi(BHA)(H-BHA)] 3 in 75% yield (based on Bi). To obtain the fully substituted product [Bi(H-BHA) 3 ], the weaker base BiPh 3 was necessary. This allows for only a single deprotonation to give the H-BHA mono-anion. Complex 3 was formed by solvent-mediated reactions, in toluene (24 h, yield 58%) or ethanol (24 h, yield 55%) at reflux, but in higher yield under solvent free conditions (60 1C, 4 h, yield 65%).
Full synthetic details and compound characterization for 1-4 are provided in the ESI. † NMR spectra were obtained on 1-4 in dry d 6 -DMSO. In the 1 H NMR spectrum of [Bi 2 (BHA) 3 ] 1, the resonances assigned to the NH and OH in benzohydroxamic acid, at 11.19 and 9.05 ppm respectively are absent (Fig. S5, ESI † ). While the o-H and p-H protons shift to a lower frequency on complexation with Bi (7.43 to 7.33 and 7.50 to 7.33 ppm), the m-H protons shift to higher frequency (7.76 to 7.70 ppm). Suggesting electronic and structural fluxionality in the H-BHA ligand, the spectrum of 2 (Fig. S8, ESI †) shows resonances for both NH (0.5 H) and OH (0.5 H) at 11.14 and 9.02 ppm respectively. In contrast, complex 3 shows only a broad NH resonance at the higher frequency value of 12.48 ppm (Fig. S11 , ESI †). The spectrum of the oxido-cluster 4 has the most acidic NH with the proton resonating at 13.66 ppm (Fig. S13, ESI †) .
The sensitivity of complex 1 to hydrolysis is apparent in the 1 H NMR spectrum collected in d 6 -DMSO, wherein the relative integral value for the NH signal at 13.60 ppm, when it becomes apparent, increases slowly over time. A similar behaviour of hydrolysis was recently reported for various bismuth oxido-nitrates and carboxylates, mainly on the basis of electrospray mass spectrometry and isolation of crystalline intermediates. [18] [19] [20] So far, single crystal X-ray structure analyses exist for the most prominent cluster nuclearities {Bi 6 }, {Bi 22 16.5 ]. 23 It might be assumed that clusters with such a {Bi 24 }-oxido core are representative of the hydrolysis step directly following the prominent {Bi 22 } clusters ( Fig. S1-S3 , ESI †). 21 Additionally, two bismuth atoms (Bi14 and Bi17 in Fig. S4 , ESI †) could be regarded as being on their way to attach to the cluster core upon additional hydrolysis. However, not all of the peripheral 10 bismuth atoms of 4 are found in positions close to those in the highly condensed {Bi 38 O 45 } clusters and it is assumed that dynamic coordination behaviour is crucial to further cluster growth processes. Most probably, coordination of single bismuth atoms (rather than larger moieties) prior to hydrolysis/condensation at the periphery of the cluster is an important step upon cluster growth, demonstrated here for the first time by a snapshot. It is assumed that ligands bound to the surface will control the kinetics of cluster growth, as it is reported for example for the growth of nanoparticles using surfactants. 24 The bactericidal activity of benzohydroxamic acid and complexes 1-4 was assessed against three laboratory strains of H. pylori: B128, 251 and 26695, using compound concentrations ranging from 25 to 0.024 mg mL
À1
. The Minimum Inhibitory Concentration (MIC) of each was determined by the Agar Diffusion method. The benzohydroxamic acid showed no activity against any of the H. pylori strains 425 mg mL
. In contrast, as shown in Table 1 , the bismuth complexes display excellent anti-bacterial activity against all three strains. Interestingly, any slow hydrolysis that takes the di-anion BHA (1) to the mono-anion H-BHA (2, 3) within a complex appears to have little or no impact on the bactericidal properties.
These are remarkably low MIC values, with the only close comparison being with some amino-arenesulfonates which showed activities as low as MIC 0.05 mg mL À1 (0.06 mM), e. . 29 These results indicate that both the structural chemistry and the anti-bacterial activity of bismuth(III) hydroxamates requires further investigation. As such, we are now currently expanding the breadth of complexes being studied. 
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